Emily K. Sims
@EmKSims
Followers
688
Following
901
Media
42
Statuses
358
Physician scientist at Indiana University
Indianapolis, IN
Joined June 2018
As always, such a pleasure to work with Erin Templeman from the @UniofExeter team, @RAOram, and Lauric Ferrat, as well as an excellent team of collaborators like @cevansmo @catespeake and others who are not on this platform. @IUSweetTweets
0
1
5
3. Risk scores like HbA1c and metabolic indices performed better in adults 4. Unique patterns suggest a need for age-tailored screening and follow-up
1
0
6
2. Unlike those were were single Ab positive or met stage 1 T1D criteria, adults with stage 2 T1D at screening progressed at the same rate as children (78% in 5 years)
0
0
3
We found important differences exist in screening and progression amongst children and adults. For example: 1. Adults were more likely to screen single Ab positive compared to kids
1
0
3
Super excited this paper on islet autoantibody positive adults is finally online- we analyzed screening and #T1D progression in 100K adult relatives screened as part of @T1D_TrialNet . Available at:
diabetesjournals.org
OBJECTIVE. More than half of incident type 1 diabetes (T1D) occurs in adults, yet research on disease progression predominantly focuses on at-risk children
3
5
13
Really excited to share this super translational project from rockstar @chaipoorva ! Islets and T cells and EVs- what more could you want ❤️?
Beta cell extracellular vesicles carry PD-L1 and suppress CD8+ T cells. EV PD-L1 is increased in AAB+ individuals, correlating with residual beta cell function. Potential #biomarker for #T1D heterogeneity. #Diabetes @IUSweetTweets @emksims @chaipoorva
https://t.co/EODcGN0O5d
1
5
22
Should be a good one!
Join @TeresaMastracci , @claus_jorgensen , Maureen Gannon, and me at the Gordon Research Conference (GRC) on Pancreatic Diseases in June - "where the endocrine and exocrine pancreas meet". Registration is now open https://t.co/b8sBXNiglF
0
1
3
Excited to work with this awesome team!
Thrilled to share our study: Risk associated with single autoantibody shifts after age 10, with men at higher T1D risk. Thanks to @EmKsims, @RAOram, @FerratLauric, and @T1D_TrialNet for their support. Read full press release here: https://t.co/MKgNbbL7Tm
#T1D #DiabetesResearch
0
0
5
👋Meet us in #Indianapolis for our Complimentary CE Dinner Meeting on #Type1Diabetes on Monday, June 17th! ➡️ https://t.co/jq0yq7ieID
@EmKSims
#Diabetes #ContinuingEducation #HealthcareProfessionals #Continuingprofessionaleducation #FOAMed #endocrinology
0
1
0
Congrats to the global experts recognized as 2024 @WIELDvoice Trailblazers, especially @IUMedSchool Drs. Evans-Molina & DiMeglio and @EliLillyandCo Dr. Gimeno. We're proud and fortunate to have many female leaders in diabetes making an impact in Indiana! https://t.co/P4WV3K99hN
1
3
21
Great work by @JacobsenLM and @Heba_T1D supporting the idea that metabolic endpoints can give us a quick readout of T1D disease modification. And we know based on @DrPeteTaylor and Colin Dayan's data that these changes have clinical relevance for our patients with T1D!
@T1D_TrialNet identifies earlier trial end points that demonstrate a beneficial treatment effect at 6 months and predict benefit out to 12 months. This could allow for shorter early phase trials or adaptive designs. @ADA_Pubs Read Here➡️ https://t.co/ZgSxKOdOhX
0
0
7
Super excited for one of the best meetings of the year!
Registration is now open to attend the 20th Immunology of Diabetes Society Congress in Bruges, Belgium on Nov 4-8, 2024! Learn more about this year's program, register and submit an abstract by visiting https://t.co/i3FZwiZdVh.
#T1DResearch #DiabetesResearch #IDS2024
0
0
11
Do metabolic measures perform similarly for predicting T1D vs. assessing immunotherapy? Not necessarily. However, combined glucose and C-peptide measures were consistent performers for both purposes. Check out at https://t.co/HXp2g2GZvP ! @T1D_TrialNet @IUSweetTweets
0
1
7
Attending #nPOD2024! Come to our @WIELDvoice breakfast panel where we discuss opportunities & barriers to leadership.
Attending nPOD ( https://t.co/iq7IdHTz3v)? Then attend our breakfast panel on barriers to leadership as well! #nPOD2024 @LinnemannLab @rmirmira @jessdunnephd @gFousteri @TseHubert @DiabetesnPOD
0
6
12
So excited to see where this important work goes!
Thrilled to represent @IUDeptPeds and co-lead the newly funded Heartland Children’s Nutrition Collaborative with @ssimsek22 from @PurdueFoodSci. We're extremely grateful for the Ricks Family Foundation's investment in pediatric health and precision nutrition research
0
0
4
This was a very fun project to work on. I'd like to congratulate the whole team, in special Milene Vallejo (not on Twitter) for the hard work. @smpowell16 @byu_sam @EmKSims @MirmiraLab @rmirmira @uabmedicine @BYU @IUSweetTweets @sciencePNNL @OmicsPNNL @UChicagoMed (6/n)
1
1
4
0
0
1
(6/6) TLDR: Drugs targeting beta cell health may have potential as agents in a combination regimen to improve insulin secretion in T1D. Next step? Fully powered TADPOL trial in new onset T1D! Find out more at:
1
1
1
(5/6) Transcriptomics and proteomics of DFMO-treated human islets exposed to cytokine stress revealed alterations in mRNA translation, nascent protein transport, and protein secretion as potential mechanisms of effect.
1
0
1